Margherita Bodini

Siena, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Human monoclonal antibodies targeting subdominant meningococcal antigens confer cross-protection against gonococcus.

Human monoclonal antibodies targeting subdominant meningococcal antigens confer cross-protection against gonococcus.

Journal: Science translational medicine
Published: May 21, 2025

Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014.

Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014.

Journal: Human vaccines & immunotherapeutics
Published: July 22, 2024

Author Correction: Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles.

Author Correction: Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles.

Journal: NPJ vaccines
Published: January 25, 2024

Classification of Neisseria meningitidis genomes with a bag-of-words approach and machine learning.

Classification of Neisseria meningitidis genomes with a bag-of-words approach and machine learning.

Journal: iScience
Published: July 27, 2023

Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles.

Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles.

Journal: NPJ vaccines
Published: June 23, 2023

OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans.

OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans.

Journal: NPJ vaccines
Published: November 04, 2022

Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines.

Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines.

Journal: mSphere
Published: September 21, 2022

Dissecting the Human Response to Staphylococcus aureus Systemic Infections.

Dissecting the Human Response to Staphylococcus aureus Systemic Infections.

Journal: Frontiers in immunology
Published: July 29, 2021

Systematic characterization of human response to H1N1 influenza vaccination through the construction and integration of personalized transcriptome response profiles.

Systematic characterization of human response to H1N1 influenza vaccination through the construction and integration of personalized transcriptome response profiles.

Journal: Scientific reports
Published: June 11, 2021

Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children.

Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children.

Journal: Human vaccines & immunotherapeutics
Published: December 16, 2020

Deconvolution of intergenic polymorphisms determining high expression of Factor H binding protein in meningococcus and their association with invasive disease.

Deconvolution of intergenic polymorphisms determining high expression of Factor H binding protein in meningococcus and their association with invasive disease.

Journal: PLoS pathogens
Published: September 30, 2020

Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.

Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.

Journal: mSphere
Published: September 17, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026